Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4+ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2-/-γc-/- Mouse

被引：60

作者：

Choudhary, Shailesh K. ^{[1
]}

Rezk, Naser L. ^{[2
]}

Ince, William L. ^{[3
]}

Cheema, Manzoor ^{[1
]}

Zhang, Liguo ^{[4
]}

Su, Lishan ^{[3
,4
]}

Swanstrom, Ronald ^{[3
]}

Kashuba, Angela D. M. ^{[2
]}

Margolis, David M. ^{[1
,4
,5
]}

机构：

[1] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA

[2] Univ N Carolina, Sch Pharm, Chapel Hill, NC 27599 USA

[3] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA

[4] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA

[5] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA

来源：

JOURNAL OF VIROLOGY | 2009年 / 83卷 / 16期

关键词：

IN-VITRO; ANTIRETROVIRAL THERAPY; RHESUS MACAQUES; MICE; INFECTION; TRANSMISSION; TENOFOVIR; EMTRICITABINE; REPLICATION; RALTEGRAVIR;

D O I：

10.1128/JVI.00580-09

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A small animal model that reproduces human immunodeficiency virus type 1 (HIV-1) pathogenesis may allow modeling of new therapeutic strategies in ways not approachable in mononuclear cell culture. We find that, as in humans, combination antiretroviral therapy (ART) in humanized (hu-) Rag2(-/-)gamma(-/-)(c) mice allows suppression of viremia below the limits of detection and recovery of CD4(+) cells, while interruption of ART results in viral rebound and renewed loss of CD4(+) T cells. Failure of ART in infected mice is associated with the appearance of drug resistance mutations. The hu-Rag2(-/-)gamma(-/-)(c) mouse may therefore facilitate testing of novel approaches to HIV replication and persistence.

引用

页码：8254 / 8258

页数：5

共 5 条

[1] Latent HIV-1 Infection of Resting CD4+ T Cells in the Humanized Rag2-/- γc-/- Mouse
Choudhary, Shailesh K.
Archin, Nancie M.
Cheema, Manzoor
Dahl, Noelle P.
Garcia, J. Victor
Margolis, David M.
JOURNAL OF VIROLOGY, 2012, 86 (01) : 114 - 120
[2] Plasma Inflammatory Biomarkers Predict CD4+ T-cell Recovery and Viral Rebound in HIV-1 Infected Africans on Suppressive Antiretroviral Therapy
Kroeze, Stefanie
Rossouw, Theresa M.
Steel, Helen C.
Wit, Ferdinand W.
Kityo, Cissy M.
Siwale, Margaret
Akanmu, Sulaimon
Mandaliya, Kishor
De Jager, Marleen
Ondoa, Pascale
Reiss, Peter
De Wit, Tobias F. Rinke
Kootstra, Neeltje A.
Hamers, Raph L.
JOURNAL OF INFECTIOUS DISEASES, 2021, 224 (04) : 673 - 678
[3] Short-term Treatment With Interferon Alfa Diminishes Expression of HIV-1 and Reduces CD4+ T-Cell Activation in Patients Coinfected With HIV and Hepatitis C Virus and Receiving Antiretroviral Therapy
Moron-Lopez, Sara
Gomez-Mora, Elisabet
Salgado, Maria
Ouchi, Dan
Puertas, Maria C.
Urrea, Victor
Navarro, Jordi
Jou, Antoni
Perez, Mercedes
Tural, Cristina
Clotet, Bonaventura
Montaner, Luis J.
Blanco, Julia
Crespo, Manuel
Martinez-Picado, Javier
JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (06) : 1008 - 1012
[4] Rab11-FIP1C Is Dispensable for HIV-1 Replication in Primary CD4+ T Cells, but Its Role Is Cell Type Dependent in Immortalized Human T-Cell Lines
de Cespedes, Melissa V. Fernandez V.
Hoffman, Huxley K.
Carter, Hannah
Simons, Lacy M.
Naing, Lwar
Ablan, Sherimay D.
Scheiblin, David A.
Hultquist, Judd F.
van Engelenburg, Schuyler B.
Freed, Eric O.
JOURNAL OF VIROLOGY, 2022, 96 (23)
[5] Adult AIDS-Like Disease in a Novel Inducible Human Immunodeficiency Virus Type 1 Nef Transgenic Mouse Model: CD4+ T-Cell Activation Is Nef Dependent and Can Occur in the Absence of Lymphophenia
Rahim, Mir Munir Ahmed
Chrobak, Pavel
Hu, Chunyan
Hanna, Zaher
Jolicoeur, Paul
JOURNAL OF VIROLOGY, 2009, 83 (22) : 11830 - 11846

← 1 →